Research Topics
| Matthew H G KatzSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomyMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg 248:1098-102. 2008..To describe our approach to resection of pancreatic head cancers, which involve 1 or both of the first-order branches of the superior mesenteric vein (SMV)...
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinomaMatthew H G Katz
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 16:836-47. 2009..We evaluated long-term survival and patterns of recurrence in patients treated for PC with contemporary staging and multimodality therapy...- Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiationMatthew H G Katz
Department of Surgery, The University of California, Orange, CA, USA
Ann Surg Oncol 17:1794-801. 2010..We evaluated CA 19-9 as a marker of therapeutic response, completion of therapy, and survival in patients enrolled on two recently reported clinical trials... - Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing Wei D Tzeng
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:2045-53. 2012..By means of this system, we sought to analyze outcomes of patients with resectable anatomy but heterogeneous biology and physiology who were treated with neoadjuvant therapy... - Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancerMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA
J Gastrointest Surg 16:68-78; discussion 78-9. 2012..To determine the influence of neoadjuvant chemoradiation and standardized dissection of the superior mesenteric artery upon the oncologic outcome of patients with localized pancreatic adenocarcinoma... - Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trialMatthew H G Katz
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
Ann Surg Oncol 18:3615-22. 2011..We conducted a phase II trial to assess the survival duration and quality of life of patients who received adjuvant interferon-based chemoradiation for pancreatic adenocarcinoma after pancreaticoduodenectomy... - Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Am Coll Surg 206:833-46; discussion 846-8. 2008..There is no optimal treatment schema for this distinct stage of disease, so the role of surgery is undefined... - Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapyChing Wei D Tzeng
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
HPB (Oxford) 14:365-72. 2012..Following potentially curative resection at this centre, patients with pancreatic adenocarcinoma (PAC) are routinely enrolled in a programme of clinical and radiographic surveillance. This study sought to evaluate its diagnostic yield... - A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinomaChristina L Roland
Division of Surgery, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Gastrointest Surg 16:2056-63. 2012..However, the use of the LNR to predict distant recurrence risk remains unknown. The purpose of this study was to determine if the LNR is associated with distant recurrence risk... - Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patientsChing Wei D Tzeng
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
HPB (Oxford) 14:506-13. 2012..The relationships between extent of hepatectomy, postoperative VTE and bleeding events were evaluated using the National Surgical Quality Improvement Program (NSQIP) database... - Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 118:5749-56. 2012..In this study, the authors sought to determine the rate at which neoadjuvant therapy is associated with a reduction in the size or stage of borderline resectable tumors... - Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancerMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA
Arch Surg 147:513-9. 2012..To calculate conditional survival estimates for patients with pancreatic adenocarcinoma... - Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resectionRyan M Thomas
Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Gastrointest Surg 16:1696-704. 2012..Resection of certain recurrent malignancies can prolong survival, but resection of recurrent pancreatic ductal adenocarcinoma is typically contraindicated because of poor outcomes... - Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniquesMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 215:e11-8. 2012..The technical approaches we have described here can be used as a basic foundation for operative safety and efficiency during these challenging operations... - Current status of adjuvant therapy for pancreatic cancerMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Oncologist 15:1205-13. 2010..Well-designed prospective trials are needed to define the optimal adjuvant or neoadjuvant therapy strategy for these patients... 
Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approachMatthew H G Katz
Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 207:106-20. 2008- Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trialMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 18:337-44. 2011..Standardization of surgical and pathologic techniques is crucial to the interpretation of studies evaluating adjuvant therapies for pancreatic cancer (PC)... - Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumorsMaria Q B Petzel
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:4078-84. 2012.... - Tumor-node-metastasis staging of pancreatic adenocarcinomaMatthew H G Katz
Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
CA Cancer J Clin 58:111-25. 2008.... - Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancerHop S Tran Cao
Department of Surgery, University of California at San Diego, California, USA
Mol Cancer Ther 9:2068-78. 2010..Our results suggest the potential of this therapeutic paradigm against pancreatic cancer in the adjuvant and maintenance settings... - Current diagnosis and management of unusual pancreatic tumorsMelinda M Mortenson
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg 196:100-13. 2008.... - Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin CLaura A Lambert
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 16:2181-7. 2009..This study analyzes the incidence and risk factors for developing neutropenia following MMC-HIPEC combined with CRS... - Associated vascular injury in patients with bile duct injury during cholecystectomyAlex M Keleman
University of California, Irvine Medical Center, Orange, California, USA
Am Surg 77:1330-3. 2011.... - Serum brain naturietic peptide measurements reflect fluid balance after pancreatectomyRichard N Berri
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4008, USA
J Am Coll Surg 214:778-87. 2012..We hypothesized that sequential measurement of currently available serum proteins will indicate fluid balance... - Current concepts in multimodality therapy for retroperitoneal sarcomaMatthew H G Katz
The University of Texas, MD Anderson Cancer Center, Department of Surgical Oncology, Houston, TX 77030, USA
Expert Rev Anticancer Ther 7:159-68. 2007.... - Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosisMatthew H G Katz
Department of Surgery, University of California San Diego, San Diego, California 92103, USA
Hepatogastroenterology 51:842-6. 2004..CONCLUSIONS: Histopathologic features of non-pancreatic periampullary adenocarcinomas significantly differentiate them from pancreatic adenocarcinoma and contribute to their relatively favorable long-term outcome following resection...